TEANECK, N.J. — Phibro Animal Health Corp. has announced plans to establish a biotech facility producing a range of animal health vaccines on the IDA Ireland Finisklin Business Park in Sligo, Ireland, creating up to 150 jobs during the next 5 years.
The project is supported by the Irish Government through IDA Ireland.
Phibro had $764 million in annual sales in more than 65 countries during its most recent fiscal year and employs over 1,400 people globally. The Sligo plant will be the company’s first biologicals manufacturing location in Europe and will allow Phibro to expand its presence. . .